---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-017118"
form_type: "8-K"
ticker: "OTLK"
cik: "0001649989"
company_name: "Outlook Therapeutics, Inc."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:05:30.953774+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Outlook Therapeutics receives Nasdaq minimum bid price deficiency notice; 180-day cure period

## Summary
- Received Nasdaq letter on Feb 18, 2026, for closing bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days, until August 17, 2026, to regain compliance.
- To regain compliance, bid price must close at $1.00+ for at least 10 consecutive business days.
- If not compliant by Aug 17, may be eligible for additional 180-day period if it meets other standards.
- Company will monitor bid price and evaluate options including reverse stock split.

## SEC filing metadata
- accession: 0001104659-26-017118
- form_type: 8-K
- ticker: OTLK
- cik: 0001649989
- company_name: Outlook Therapeutics, Inc.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649989/000110465926017118/0001104659-26-017118-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649989/000110465926017118/tm266772d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-017118
- JSON: https://secwatch.observer/filing/0001104659-26-017118.json
- Plain text: https://secwatch.observer/filing/0001104659-26-017118.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.